Pharma Promotion / Incidents by company / Amgen
Amgen
21 incidents / jurisdictions: United States / sum of amounts reported: USD 1.94 bn
| Date | Jurisdiction | Outcome | What happened (source) | Damages / settlement / fine |
|---|---|---|---|---|
| 2025 | United States | Judgment against company | In May 2025, a jury awarded Regeneron $406 million from Amgen, which engaged in anticompetitive practices to increase sales of its cholesterol-reduction drug Repatha at the expense of Regeneron's Pral Wikipedia: Amgen（Legal issues） | $406 million |
| 2019-04-25 | United States | Settlement | Two Pharmaceutical Companies Agree to Pay a Total of Nearly $125 Million to Resolve Allegations That They Paid Kickbacks Through Copay Assistance Foundations U.S. Department of Justice + 1 more reports | $125 Million / $124.75 million |
| 2018-09-17 | United States | Filed / under investigation | United States v. Amgen, Inc. District Court, E.D. New York | — |
| 2018-01-26 | United States | Other | Amgen Inc. v. Hargan Court of Appeals for the D.C. Circuit | — |
| 2018-01-26 | United States | Filed / under investigation | Amgen Inc. v. Price District Court, District of Columbia | — |
| 2017-01-17 | United States | Filed / under investigation | United States ex rel. Coyne v. Amgen, Inc. District Court, E.D. New York | — |
| 2015-05-26 | United States | Other | Steve Harris v. Amgen, Inc. Court of Appeals for the Ninth Circuit | — |
| 2014-10-30 | United States | Other | Harris v. Amgen, Inc. Court of Appeals for the Ninth Circuit + 1 more reports | — |
| 2013-10-23 | United States | Other | Steve Harris v. Amgen, Inc. Court of Appeals for the Ninth Circuit | — |
| 2013-07-11 | United States | Settlement | Ventura County-based Amgen Inc. Pays Over $15 Million To Resolve Allegations That It Illegally Marketed Cancer Drug With Kickbacks U.S. Department of Justice | $15 Million |
| 2013-06-04 | United States | Other | Steve Harris v. Amgen, Inc. Court of Appeals for the Ninth Circuit | — |
| 2013-04-16 | United States | Settlement | Amgen to Pay U.S. $24.9 Million to Resolve False Claims Act Allegations U.S. Department of Justice | $24.9 Million |
| 2012 | United States | Settlement | 2012 | Amgen | $762 million | Off-label promotion, kickbacks | Aranesp | False Claims Act, FDCA Wikipedia: List of largest pharmaceutical settlements + 1 more reports | $762 million |
| 2012 | United States | Guilty plea / conviction | In December 2012, Amgen plead guilty and agreed to pay $150 million in criminal penalty and $612 million to resolve 11 related whistleblower complaints regarding the improper marketing of anemia drug Wikipedia: Amgen（Legal issues） | $150 million / $612 million |
| 2011-07-22 | United States | Filed / under investigation | New York v. Amgen Inc. Court of Appeals for the First Circuit | — |
| 2010-09-20 | United States | Filed / under investigation | United States Ex Rel. Westmoreland v. Amgen, Inc. District Court, D. Massachusetts | — |
| 2010-04-23 | United States | Filed / under investigation | US EX REL. WESTMORELAND v. Amgen, Inc. District Court, D. Massachusetts + 1 more reports | — |
| 2009-07-14 | United States | Filed / under investigation | Steve Harris v. Amgen, Inc. Court of Appeals for the Ninth Circuit + 1 more reports | — |
| 2008-12-17 | United States | Filed / under investigation | In Re Epogen & Aranesp Offlabel Marketing & Sales Practices Litigation District Court, C.D. California | — |
| 2008-04-08 | United States | Filed / under investigation | In Re Epogen & Aranesp Off-Label Marketing & Sales Practices Litigation United States Judicial Panel on Multidistrict Litigation | — |
| 2008-02-01 | United States | Filed / under investigation | In Re Amgen Inc. Securities Litigation District Court, C.D. California | — |
Amounts are extracted mechanically from headlines and summaries and kept only when Jev confirms they are paid by the company. The same case reported by several articles may be counted more than once, so totals are indicative. Check the sources.